AGE ZERO

Umbilical cord stem cells for medical or veterinary use; Pharmaceutical preparations for use in tissue engineered and cell based veterinary and medical therapies for use in the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations manufactured or modified by genetic engineering in the form of umbilical cord stem cells for veterinary and medical purposes; Pharmaceutical and veterinary preparations, namely, gene therapy products in the form of umbilical cord stem cells for therapeutic medical use; Biochemical preparations for medical or veterinary purposes, namely, preparations for use in gene therapy for the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; umbilical cord stem cells for clinical use; Orthobiologic preparations, namely, biologic preparations in the nature of umbilical cord stem cells to achieve symptomatic relief and cures from various orthopedic diseases; Pharmaceutical preparations for the treatment of osteoarthritis; pharmaceutical preparations for the treatment of spinal cord injury